What Is a Peptide? A Plain-English Beginner's Guide

If you've spent time on social media this year, you've probably heard "peptide" used as if it named one thing. It doesn't. "Peptide" describes a kind of molecule, not a product, a promise or a verdict on safety. Insulin is a peptide. So are some of the best-studied drugs in medicine. So are compounds that have barely been tested in people.

This guide gives you a simple way to think about all of them. We'll define a few terms, build a couple of mental pictures, and be clear about where the science is solid and where it isn't.

What should you ask about any peptide?

For any peptide you hear about, ask four questions:

1. What is it made of? (structure)
2. What does it bind to? (receptors)
3. What happens next? (signaling and effects)
4. What's the evidence, and where did the product come from? (evidence and sourcing)

The rest of this guide takes them in order.

What is a peptide made of?

Start with amino acids, the small molecules that serve as the building blocks of proteins. There are 20 of them ².

Now picture a string of beads. Each bead is an amino acid. Link beads together with a specific chemical connection called a peptide bond, and you get a chain. A short chain is a peptide.

How short? The National Human Genome Research Institute, part of NIH, defines a peptide as a short chain of amino acids, typically 2 to 50 ¹. A longer chain is a polypeptide, and a protein is made of one or more polypeptides folded into a complex three-dimensional shape ^1,3.

Those cutoffs are conventions, not laws of nature. Insulin has 51 amino acids across two linked chains and is still routinely called a peptide hormone. So think of it as a spectrum: single beads, then a short string (peptide), then a long string (polypeptide), then a folded, sculpted structure (protein).

Order matters too. The sequence of beads determines a peptide's shape, and its shape determines what it can do. Oxytocin is only nine amino acids long ⁶.

What does a peptide bind to?

Many peptides that act as hormones or messengers don't need to enter cells. Instead, they bind to receptors, which are proteins on the surface of cells ⁴.

Think of receptors as parking spots, each shaped for a particular kind of vehicle. A peptide with the right shape can pull in, and one with the wrong shape can't. That fit is why peptides can be selective.

Two consequences follow:

• A peptide only affects cells that have its parking spot. No receptor, no direct effect.
• The same parking spot can exist in many tissues. A peptide whose receptor sits in the gut, the pancreas and the brain can act in all three.

What happens after a peptide binds?

Parking is only the start. When a peptide binds, the receptor triggers a chain of events inside the cell called downstream signaling. This often runs through "second messengers", small molecules that relay and amplify the signal ^4,5. One hormone molecule can generate many copies of a second messenger, and a single receptor type can set off more than one pathway ⁵.

That is why one peptide rarely does just one thing:

• Oxytocin, made in the hypothalamus and released from the pituitary gland, stimulates uterine contractions during labor and milk release during breastfeeding, and it is thought to influence social and maternal behavior ^6,7.
• GLP-1, a gut hormone, prompts insulin release, slows stomach emptying, and acts on brain areas that process hunger and fullness. Medicines that mimic it bring several of those effects along ⁸.

Where do peptides come from?

Your body makes many peptides itself. The pancreas makes insulin to regulate blood sugar. The nervous system releases endorphins that block pain signals. Growth hormone–releasing hormone tells the pituitary to release growth hormone ⁹. Other peptides come from digesting proteins in foods like meat, eggs and legumes, and scientists can also make peptides in the lab ⁹.

Which peptides are approved medicines?

Peptide medicines have been part of medicine for about a century. A 2025 review in Signal Transduction and Targeted Therapy traces them to 1922, when Frederick Banting and colleagues first extracted insulin from animals and used it to treat type 1 diabetes. The same review counts nearly 100 approved peptide drugs worldwide ¹⁰. FDA-approved examples include ¹¹:

• Insulin, for blood sugar control in diabetes
• Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), for type 2 diabetes and obesity
• Teriparatide (Forteo), for osteoporosis
• Leuprolide (Lupron Depot), used in prostate cancer and endometriosis
• Bremelanotide (Vyleesi), for low sexual desire in premenopausal women
• Oxytocin, used to induce or strengthen labor contractions

What these medicines have in common isn't just that they're peptides. Each went through clinical trials and FDA review for a specific use. Many are injected because digestive enzymes in the gut break peptides down quickly ¹⁰. Engineering can sometimes get around this: oral semaglutide (Rybelsus) became the first GLP-1 receptor agonist taken by mouth ¹⁰.

Why do quality and sourcing matter?

Because "peptide" names a molecule rather than a level of oversight, the same word covers products that are worlds apart. A simple three-part map:

• Prescription: FDA-approved medicines made under regulated manufacturing standards, plus drugs compounded by licensed pharmacies under specific rules.
• Gray market: unapproved compounds sold online, often labeled "for research purposes only" while being promoted for health uses.
• Black market: illegal or counterfeit products sold outside any legal framework.

Harvard Health notes that unregulated peptides may contain impurities ⁹, and PolitiFact reports that an independent testing lab found products sold online don't always match their labels ¹².

The rules are also shifting. In 2023 FDA placed BPC-157 and several other peptides on its "Category 2" list of compounding substances flagged for significant safety risks, and in 2026 it removed a number of them, BPC-157 included ¹³. In July 2026 an FDA advisory committee recommended six peptides for compounding (BPC-157, KPV, TB-500, MOTS-c, Semax and epitalon), even though FDA's own scientists opposed adding any of the seven peptides under review and judged the available evidence insufficient ¹⁴.

What don't we know yet?

• Approved peptides have large clinical trials behind them for specific uses.
• Many trending peptides have evidence mostly from cell and animal studies ⁹. A promising result in rodents is a reason to study something in humans, not proof that it works in humans.
• Long-term safety of most unapproved peptides is unknown. Some injectable peptides may trigger abnormal immune reactions ⁹.
• Combinations ("stacks") are even less studied than single compounds.

When a claim sounds certain, go back to question four: what's the evidence, and where did it come from?

The takeaway

A peptide is a short string of amino acids. Many act as messengers: they park in specific receptors and set off signaling cascades, which is why one peptide can have many effects. Some peptides are among the best-tested medicines we have, and others are experimental. The word alone doesn't tell you which is which.